CN1238213A - Medicinal capsules for improving vision and its preparing method - Google Patents
Medicinal capsules for improving vision and its preparing method Download PDFInfo
- Publication number
- CN1238213A CN1238213A CN 99115331 CN99115331A CN1238213A CN 1238213 A CN1238213 A CN 1238213A CN 99115331 CN99115331 CN 99115331 CN 99115331 A CN99115331 A CN 99115331A CN 1238213 A CN1238213 A CN 1238213A
- Authority
- CN
- China
- Prior art keywords
- gram
- radix
- grams
- myopia
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese patent medicine in the form of capsules for treating myopia is prepared from 17 Chinese medicinal matenals including ginseng, polygala root, white tuckahoe, Chinese angelica root, etc through washing, drying, grinding unifoxmly proportional mixing, ultraviolet sterilzation and then loading in capsules. Its advantages high effec on curing myopia and other eye diseases including cataract, glaucoma, eye trauma and eyeground diseases, simple preparing process, and easy degestion and absorption.
Description
The present invention relates to a kind of Chinese patent medicine for the treatment of oculopathy and preparation method thereof, a kind of Chinese patent medicine of especially treatment myopia and preparation method thereof.
Myopia is adolescent student, is engaged in a kind of commonly encountered diseases of literal work and other near work that the traditional Chinese medical science claims " closely timid disease far away ".Ancient Chinese is for writing in medicine book " the Ling Shu Miraculous Pivot or Divine Axis greatly puzzled opinion " book, " the order person, the essence of five ZANG-organs and six FU-organs also, the Chang Ying of institute that battalion defends soul is also.", record in " Ling Shu Miraculous Pivot or Divine Axis Hai Jing ", " the liver being in charge of the eyes, liver opening at eye, and liver gets blood and can look, liver-QI being connected with eyes, liver and then can Bu Wuse.”。Therefore, myopia is also the same with other oculopathy, with liver confidential relation is arranged.When read fault, in the darker local work study of light, excessively use reasons such as order, congenital defect, direct heredity and malnutrition, but overworked eyes all, damage liver blood, dispirited gas decrease or Liver and kidney two void, cause the order apoplex involving the channels and collaterals not smooth, muscle loses foster, and myopia appears in the order malfunction.So liver blood is not gone up battalion yet, refreshing labor then soul is loose, and can not adapt, and the crystal that suffers from a deficiency of the kidney does not support yet.Therefore the Chinese medicine that ancient times, the well-known doctor adopted the moisturizing of nourishing blood to calm the nerves is treated myopia, in " (Precious Book of Ophthalmology " book, put down in writing with " dingzhi pills " treatment myopia as Ming Dynasty's traditional Chinese medical science Fu Renyu, its prescription is: " each two liang of Cortex et Radix Polygalae, Rhizoma Acori Graminei; Radix Ginseng, BAIHUO refreshing each one or two; grind and be smalls; making pellets by mixing medical powder with honey, big as the seeds of a tung oil tree."; also record is near-sighted with " going back the eyeball ball " treatment in the traditional Chinese medical science rare edition book series " secretly hand down ophthalmology 72 disease pandects) "; its prescription is: " Semen Cuscutae, Rhizoma Chuanxiong, Herba Equiseti Hiemalis, Fructus Tribuli, the Radix Paeoniae Alba, Radix Rehmanniae Preparata, Radix Glycyrrhizae, Rhizoma Et Radix Notopterygii, Semen Celosiae, Flos Buddlejae, Radix Angelicae Sinensis, Fructus Lycii, Herba Cistanches, porphyrize becomes the end, refined honey becomes ball, and is big as the seeds of a tung oil tree.", the two all has certain curative effect in treatment aspect near-sighted, is exactly the manufacture method complexity but a common defective is arranged, and medicine fishy smell is arranged, and take 30 at every turn, and the patient is not easy to take and digest and assimilate.
One of purpose of the present invention provides a kind of no medicine fishy smell, and the patient takes easily and digests and assimilates, and has the medicinal capsules for improving vision of the effect of " dingzhi pills " and " going back the eyeball ball " treatment myopia concurrently.
Two of purpose of the present invention provides a kind of method of making medicinal capsules for improving vision.
Three of purpose of the present invention provides a kind of except can treating myopia, but also has the medicinal capsules for improving vision of other oculopathy of treatment.
The present invention realizes that by following approach it is with the resistance and supplementing qi medicine of calming the nerves of having one's ideas straightened out: Radix Ginseng, Radix Polygalae, Poria; Tonifying liver blood rearing movable blood medicine: Radix Angelicae Sinensis, Rhizoma Chuanxiong, the Radix Paeoniae Alba, Radix Rehmanniae Preparata; Liver-benefiting eye-brightening medicine: Herba Equiseti Hiemalis, Flos Buddlejae, Fructus Atriplicis Sibiricae, Semen Celosiae, Rhizoma Et Radix Notopterygii; Tonifying kidney for improving eyesight medicine: Fructus Lycii, Herba Cistanches, Semen Cuscutae, Rhizoma Acori Graminei; Stomach function regulating antidote: Radix Glycyrrhizae, 17 flavor Chinese medicines grind to the powder after washing and drying, and by a certain percentage with its uniform mixing, disinfection by ultraviolet light by every ball 0.25 gram, 0.5 gram, divides to put in the capsule and makes then.
The present invention can resemble can treat myopia " dingzhi pills " and " going back the eyeball ball ", and can bring into play the unique effects of oneself simultaneously again, makes other oculopathy (as cataract, glaucoma, ocular injury and retinopathy) increase and look, this be additive method can not compare.Its manufacture method is simple, does not have " dingzhi pills " and " going back the eyeball ball " complicated like that, no medicine fishy smell, and the patient is acceptant to take, and is convenient to digest and assimilate.Its dose has only their 1/2 in addition, but has the comprehensive effect that their invigorating the liver and kidney of nourishing blood is calmed the nerves, thereby can reach the purposes of treatment myopia effectively and other oculopathy.
Present domestic still do not have ready-made " dingzhi pills " and " going back the eyeball ball ".For effectiveness of the present invention is studied and clinical practice, a kind of method is that above-mentioned 17 flavor Chinese medicines are fried in shallow oil into decoction, take for 400 example myopia and other persons suffering from ocular disorders, a kind of employing the present invention, take for the patient of 700 example myopia and other ophthalmics, the result shows that the present invention has curative effect preferably, takes orally conveniently to have no side effect.Low myopia effective percentage 96%, medium myopia effective percentage are 63.5%, and the effective percentage 40.5% of high myopia simultaneously to other oculopathy such as cataract, glaucoma, ocular injury and retinopathy, also has increasing and look in various degree, and its tracing study long-term effect is more stable.Below for the concrete data of clinical practice: one, take capsule:
1. near-sighted: 1-3D 200 other ophthalmics of example: cataract 30 examples
3-6D 200 routine glaucoma 20 examples
Above 200 routine ocular injury 10 examples of 6D
Retinopathy 40 examples
2. dosage (for oral administration, medication two months):
Each 2 balls of 7-9 year (1 gram) every day three times
Each 3 balls of 10-14 year (1.5 gram) every day three times
Each 4 balls of 15-18 year (2 gram) every day three times
Be grown up each 6 balls (3 gram) every day three times
3. criterion of therapeutical effect:
Produce effects: increase look 4 row above or recover vision be 1.0 or diopter reduce to 0.
Take a turn for the better: increase look 1-3 capable or recover vision be 0.7 or diopter show and fall.
Invalid: as to increase and look 0-1 is capable, diopter does not descend or visual deterioration or diopter rise.
4. effect:
Myopia:
The produce effects invalid total effective rate that takes a turn for the better
1-3D 87 105 8 96％
3-6D 41 86 73 63.5％
6D above 2 79 119 40.5%
Other ophthalmics:
Cataract: 0 10 20 33.3%
Glaucoma: 07 13 35%
Ocular injury: 046 40%
Retinopathy: 1 15 14 55.3% 2, take decoction:
1. near-sighted: 1-3D 100 other ophthalmics of example: cataract 30 examples
3-6D 100 routine glaucoma 20 examples
Above 100 routine ocular injury 20 examples of 6D
Retinopathy 30 examples
2. criterion of therapeutical effect:
Produce effects: increase look 4 row above or recover vision be 1.0 or a luminosity reduce to 0.
Take a turn for the better: increase look 1-3 capable or recover vision be 0.7 or diopter show and fall.
Invalid: increase look 0-1 is capable, a luminosity does not descend or visual deterioration or diopter on
Rise.
3. effect:
Myopia:
The produce effects invalid total effective rate that takes a turn for the better
1-3D 35 49 16 84％
3-6D 8 43 49 51％
6D above 0 38 62 38%
Other ophthalmics:
Cataract: 06 24 20%
Glaucoma: 04 16 20%
Ocular injury: 05 15 25%
Retinopathy: 2 10 18 40%
The prescription that the present invention adopts is: Radix Ginseng: 3-6 gram, Radix Polygalae: 10-15 gram, Poria: 6-10 gram, Radix Angelicae Sinensis: 10-15 gram, Rhizoma Chuanxiong: 10-15 gram, the Radix Paeoniae Alba: 10-15 gram, Radix Rehmanniae Preparata: 15-20 gram, Herba Equiseti Hiemalis: 10-15 gram, Flos Buddlejae 10-15 gram, Fructus Atriplicis Sibiricae: 10-15 gram, Semen Celosiae: 10-15 gram, Rhizoma Et Radix Notopterygii: 3-6 gram, Fructus Lycii: 15-20 gram, Herba Cistanches: 10-15 gram, Semen Cuscutae: 10-15 gram, Rhizoma Acori Graminei: 10-15 gram, Radix Glycyrrhizae: 3 grams.
The manufacture method that the present invention adopts is: will above-mentioned 17 flavor Chinese medicines wash dry after, grind to the powder, and with its uniform mixing, disinfection by ultraviolet light then by every ball 0.25 gram, 0.5 gram, divides and puts into that capsule is interior to get final product.
The present invention has three embodiment, is specially:
Low myopia is adopted the capsule of following prescription: Radix Ginseng: 3 grams, Radix Polygalae: 10 grams, Poria: 6 grams, Radix Angelicae Sinensis: 10 grams, Rhizoma Chuanxiong: 10 grams, the Radix Paeoniae Alba: 10 grams, Radix Rehmanniae Preparata: 15 grams, Herba Equiseti Hiemalis: 10 grams, Flos Buddlejae: 10 grams, Fructus Atriplicis Sibiricae: 10 grams, Semen Celosiae: 10 grams, Rhizoma Et Radix Notopterygii: 3 grams, Fructus Lycii: 15 grams, Herba Cistanches: 10 grams, Semen Cuscutae: 10 grams, Rhizoma Acori Graminei: 10 grams, Radix Glycyrrhizae: 3 grams.
Medium myopia is adopted following prescription (usual amounts): Radix Ginseng: 6 grams, Radix Polygalae: 15 grams, Poria: 6 grams, Radix Angelicae Sinensis: 10 grams, Rhizoma Chuanxiong: 10 grams, the Radix Paeoniae Alba: 10 grams, Radix Rehmanniae Preparata: 15 grams, Herba Equiseti Hiemalis: 10 grams, Flos Buddlejae 10 grams, Fructus Atriplicis Sibiricae: 10 grams, Semen Celosiae: 15 grams, Rhizoma Et Radix Notopterygii: 6 grams, Fructus Lycii: 15 grams, Herba Cistanches: 10 grams, Semen Cuscutae: 10 grams, Rhizoma Acori Graminei: 15 grams, Radix Glycyrrhizae: 3 grams.
High myopia is adopted following prescription: Radix Ginseng: 6 grams, Radix Polygalae: 15 grams, Poria: 10 grams, Radix Angelicae Sinensis: 15 grams, Rhizoma Chuanxiong: 15 grams, the Radix Paeoniae Alba: 15 grams, Radix Rehmanniae Preparata: 20 grams, Herba Equiseti Hiemalis: 15 grams, Flos Buddlejae 15 grams, Fructus Atriplicis Sibiricae: 15 grams, Semen Celosiae: 15 grams, Rhizoma Et Radix Notopterygii: 6 grams, Fructus Lycii: 20 grams, Herba Cistanches: 15 grams, Semen Cuscutae: 15 grams, Rhizoma Acori Graminei: 15 grams, Radix Glycyrrhizae: 3 grams.
Claims (2)
1. medicinal capsules for improving vision, its prescription is: Radix Ginseng: 3-6 gram, Radix Polygalae: 10-15 gram, Poria: 6-10 gram, Radix Angelicae Sinensis: 10-15 gram, Rhizoma Chuanxiong: 10-15 gram, the Radix Paeoniae Alba: 10-15 gram, Radix Rehmanniae Preparata: 15-20 gram, Herba Equiseti Hiemalis: 10-15 gram, Flos Buddlejae 10-15 gram, Fructus Atriplicis Sibiricae: 10-15 gram, Semen Celosiae: 10-15 gram, Rhizoma Et Radix Notopterygii: 3-6 gram, Fructus Lycii: 15-20 gram, Herba Cistanches: 10-15 gram, Semen Cuscutae: 10-15 gram, Rhizoma Acori Graminei: 10-15 gram, Radix Glycyrrhizae: 3 grams.
2. medicinal capsules for improving vision, its manufacture method is: with the described Chinese medicine of claim 1 wash dry after, grind to the powder, and with its uniform mixing, disinfection by ultraviolet light by every ball 0.25 gram, 0.5 gram, divides and puts in the capsule then.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB991153316A CN1175896C (en) | 1999-04-16 | 1999-04-16 | Medicinal capsules for improving vision and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB991153316A CN1175896C (en) | 1999-04-16 | 1999-04-16 | Medicinal capsules for improving vision and its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1238213A true CN1238213A (en) | 1999-12-15 |
| CN1175896C CN1175896C (en) | 2004-11-17 |
Family
ID=5278311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB991153316A Expired - Fee Related CN1175896C (en) | 1999-04-16 | 1999-04-16 | Medicinal capsules for improving vision and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1175896C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101524514B (en) * | 2009-04-01 | 2012-02-29 | 强云升 | Medicament for curing central serous chorioretinopathy (CSCR) and preparation method thereof |
| CN102641431A (en) * | 2012-05-21 | 2012-08-22 | 修方伟 | Medicament for treating vitreous opacity |
| CN116173122A (en) * | 2022-09-24 | 2023-05-30 | 黑龙江省众目共明生物科技有限公司 | Herbal eye compress cream |
-
1999
- 1999-04-16 CN CNB991153316A patent/CN1175896C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101524514B (en) * | 2009-04-01 | 2012-02-29 | 强云升 | Medicament for curing central serous chorioretinopathy (CSCR) and preparation method thereof |
| CN102641431A (en) * | 2012-05-21 | 2012-08-22 | 修方伟 | Medicament for treating vitreous opacity |
| CN102641431B (en) * | 2012-05-21 | 2013-07-10 | 修方伟 | Medicament for treating vitreous opacity |
| CN116173122A (en) * | 2022-09-24 | 2023-05-30 | 黑龙江省众目共明生物科技有限公司 | Herbal eye compress cream |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1175896C (en) | 2004-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1857666A (en) | Chinese medicine preparation for treating senile dementia | |
| CN102631558A (en) | Medicament for treating eye disease and preparation method of medicament | |
| CN103110810A (en) | Traditional Chinese medicine preparation for treating dry eye diseases | |
| CN1066945C (en) | Chinese drug Mingmudan pill for improving eyesight and its producing method | |
| CN1159936A (en) | Medicine for preventing and treating eye diseases | |
| CN100368006C (en) | Medicine for treating cardiovascular disease | |
| CN1965996A (en) | Preparation method of Chinese medicinal capsule for treating apoplexy | |
| CN1175896C (en) | Medicinal capsules for improving vision and its preparing method | |
| CN1255178C (en) | Externally used traditional Chinese medicine preparation for treating teenager myopia and its preparing method | |
| CN1028317C (en) | pillow for preventing and treating myopia | |
| CN1160091C (en) | Medicine for treating ophthalmopathy | |
| CN107648397B (en) | Traditional Chinese medicine composition for treating liver-kidney yin deficiency and preparation method and application thereof | |
| CN114010591A (en) | Externally-applied traditional Chinese medicine gel paste for treating asthenopia and preparation method thereof | |
| CN107029037A (en) | It is a kind of to improve the eyesight-improving health care function patch of eyes based on nitric oxide principle | |
| CN1698869A (en) | Mind easing oral liquor with gen-seng and lily bulb | |
| CN1168277A (en) | Eyesight granule and its compounding process | |
| CN114452365B (en) | Traditional Chinese medicine preparation for treating chalazion | |
| CN117045762B (en) | Compound traditional Chinese medicine for treating gastric precancerous lesions and preparation method | |
| CN1201811C (en) | Chinese medicine composition for treating myopia and preparing method thereof | |
| CN1110161A (en) | Traditional Chinese Medicine preparation for mainly curing myopia | |
| CN102018789B (en) | Traditional Chinese medicine composition for alleviating asthenopia and preparation method thereof | |
| CN102727668A (en) | Chinese medicine composition with effect of alleviating asthenopia and preparation method thereof | |
| CN101843786A (en) | Chinese medicament for treating diabetic eyeground pathological changes | |
| CN1709476A (en) | Mine-tranquilizing soporific capsule | |
| CN106728581B (en) | Application of pharmaceutical composition in preparation of medicine for treating asthenopia caused by long-term visual impairment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |